Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Association Between Compliance with Triage Directions from an Organized State Trauma System and Trauma Outcomes.

Martinez B, Owings JT, Hector C, Hargrove P, Tanaka S, Moore M, Greiffenstein P, Giaimo J, Talebinejad S, Hunt JP.

J Am Coll Surg. 2017 Oct;225(4):508-515. doi: 10.1016/j.jamcollsurg.2017.06.016. Epub 2017 Aug 30.

PMID:
28865685
2.

Amelioration of murine sickle cell disease by nonablative conditioning and γ-globin gene-corrected bone marrow cells.

Pestina TI, Hargrove PW, Zhao H, Mead PE, Smeltzer MP, Weiss MJ, Wilber A, Persons DA.

Mol Ther Methods Clin Dev. 2015 Dec 2;2:15045. doi: 10.1038/mtm.2015.45. eCollection 2015.

3.

Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells.

Urbinati F, Hargrove PW, Geiger S, Romero Z, Wherley J, Kaufman ML, Hollis RP, Chambers CB, Persons DA, Kohn DB, Wilber A.

Exp Hematol. 2015 May;43(5):346-351. doi: 10.1016/j.exphem.2015.01.009. Epub 2015 Feb 12.

4.

Pursuing prosody interventions.

Hargrove PM.

Clin Linguist Phon. 2013 Aug;27(8):647-60. doi: 10.3109/02699206.2013.777121. Epub 2013 Jun 27. Review.

PMID:
23806133
5.

High-efficiency transduction of rhesus hematopoietic repopulating cells by a modified HIV1-based lentiviral vector.

Uchida N, Hargrove PW, Lap CJ, Evans ME, Phang O, Bonifacino AC, Krouse AE, Metzger ME, Nguyen AD, Hsieh MM, Wolfsberg TG, Donahue RE, Persons DA, Tisdale JF.

Mol Ther. 2012 Oct;20(10):1882-92. doi: 10.1038/mt.2012.159. Epub 2012 Aug 7.

6.

Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer.

Wilber A, Hargrove PW, Kim YS, Riberdy JM, Sankaran VG, Papanikolaou E, Georgomanoli M, Anagnou NP, Orkin SH, Nienhuis AW, Persons DA.

Blood. 2011 Mar 10;117(10):2817-26. doi: 10.1182/blood-2010-08-300723. Epub 2010 Dec 14.

7.

Transduction of human primitive repopulating hematopoietic cells with lentiviral vectors pseudotyped with various envelope proteins.

Kim YS, Wielgosz MM, Hargrove P, Kepes S, Gray J, Persons DA, Nienhuis AW.

Mol Ther. 2010 Jul;18(7):1310-7. doi: 10.1038/mt.2010.48. Epub 2010 Apr 6.

8.

A zinc-finger transcriptional activator designed to interact with the gamma-globin gene promoters enhances fetal hemoglobin production in primary human adult erythroblasts.

Wilber A, Tschulena U, Hargrove PW, Kim YS, Persons DA, Barbas CF 3rd, Nienhuis AW.

Blood. 2010 Apr 15;115(15):3033-41. doi: 10.1182/blood-2009-08-240556. Epub 2010 Feb 26.

9.

Amelioration of murine beta-thalassemia through drug selection of hematopoietic stem cells transduced with a lentiviral vector encoding both gamma-globin and the MGMT drug-resistance gene.

Zhao H, Pestina TI, Nasimuzzaman M, Mehta P, Hargrove PW, Persons DA.

Blood. 2009 Jun 4;113(23):5747-56. doi: 10.1182/blood-2008-10-186684. Epub 2009 Apr 13.

10.

Correction of murine sickle cell disease using gamma-globin lentiviral vectors to mediate high-level expression of fetal hemoglobin.

Pestina TI, Hargrove PW, Jay D, Gray JT, Boyd KM, Persons DA.

Mol Ther. 2009 Feb;17(2):245-52. doi: 10.1038/mt.2008.259. Epub 2008 Dec 2.

11.

Procedures for using clinical practice guidelines.

Hargrove P, Griffer M, Lund B.

Lang Speech Hear Serv Sch. 2008 Jul;39(3):289-302. doi: 10.1044/0161-1461(2008/028).

PMID:
18596287
12.

Globin lentiviral vector insertions can perturb the expression of endogenous genes in beta-thalassemic hematopoietic cells.

Hargrove PW, Kepes S, Hanawa H, Obenauer JC, Pei D, Cheng C, Gray JT, Neale G, Persons DA.

Mol Ther. 2008 Mar;16(3):525-33. doi: 10.1038/sj.mt.6300394. Epub 2008 Jan 15.

13.

In vivo bioluminescence imaging for early detection and monitoring of disease progression in a murine model of neuroblastoma.

Dickson PV, Hamner B, Ng CY, Hall MM, Zhou J, Hargrove PW, McCarville MB, Davidoff AM.

J Pediatr Surg. 2007 Jul;42(7):1172-9.

PMID:
17618876
14.

Extended beta-globin locus control region elements promote consistent therapeutic expression of a gamma-globin lentiviral vector in murine beta-thalassemia.

Hanawa H, Hargrove PW, Kepes S, Srivastava DK, Nienhuis AW, Persons DA.

Blood. 2004 Oct 15;104(8):2281-90. Epub 2004 Jun 15.

PMID:
15198957
15.

Successful treatment of murine beta-thalassemia using in vivo selection of genetically modified, drug-resistant hematopoietic stem cells.

Persons DA, Allay ER, Sawai N, Hargrove PW, Brent TP, Hanawa H, Nienhuis AW, Sorrentino BP.

Blood. 2003 Jul 15;102(2):506-13. Epub 2003 Mar 27.

PMID:
12663444
17.

Expression of MRP4 confers resistance to ganciclovir and compromises bystander cell killing.

Adachi M, Sampath J, Lan LB, Sun D, Hargrove P, Flatley R, Tatum A, Edwards MZ, Wezeman M, Matherly L, Drake R, Schuetz J.

J Biol Chem. 2002 Oct 11;277(41):38998-9004. Epub 2002 Jun 24.

18.

Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood.

Hanawa H, Kelly PF, Nathwani AC, Persons DA, Vandergriff JA, Hargrove P, Vanin EF, Nienhuis AW.

Mol Ther. 2002 Mar;5(3):242-51.

21.

Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein.

Lecureur V, Sun D, Hargrove P, Schuetz EG, Kim RB, Lan LB, Schuetz JD.

Mol Pharmacol. 2000 Jan;57(1):24-35.

PMID:
10617675
22.

High-efficiency transduction and long-term gene expression with a murine stem cell retroviral vector encoding the green fluorescent protein in human marrow stromal cells.

Marx JC, Allay JA, Persons DA, Nooner SA, Hargrove PW, Kelly PF, Vanin EF, Horwitz EM.

Hum Gene Ther. 1999 May 1;10(7):1163-73.

PMID:
10340548
23.

A Format for Identifying Interactions Among Measures of Communication Skills: A Case Study.

Hargrove PM, Frerichs J, Heino K.

Lang Speech Hear Serv Sch. 1999 Jan 1;30(1):11-25. doi: 10.1044/0161-1461.3001.11.

PMID:
27764284
24.

Targeted integration of a recombinant globin gene adeno-associated viral vector into human chromosome 19.

Bertran J, Yang Y, Hargrove P, Vanin EF, Nienhuis AW.

Ann N Y Acad Sci. 1998 Jun 30;850:163-77.

PMID:
9668538
26.

Gene transfer into hematopoietic cells.

Nienhuis AW, Bertran J, Hargrove P, Vanin E, Yang Y.

Stem Cells. 1997;15 Suppl 1:123-34. Review.

27.

Evidence for development of distinction of voice onset time in a child with left-hemisphere lesion.

Paulson-Sebold K, Hansen LR, Seikel JA, Hargrove PM, Chermak GD.

Percept Mot Skills. 1995 Dec;81(3 Pt 1):1001-2.

PMID:
8668420
28.

Achieving cultural sensitivity: a process, not a product.

Hargrove PM, Katz KB.

Clin Commun Disord. 1992 Summer;2(3):13-22. Review. No abstract available.

PMID:
1301899
29.

The use of stress by language-impaired children.

Hargrove PM, Sheran CP.

J Commun Disord. 1989 Oct;22(5):361-73.

PMID:
2600198
30.

Clarification requests of normal and language-impaired children.

Hargrove PM, Straka EM, Medders EG.

Br J Disord Commun. 1988 Apr;23(1):51-61. No abstract available.

PMID:
3245933

Supplemental Content

Loading ...
Support Center